20
Raks Pharma Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from WHO-GMP.
One of their notable products is CARVEDILOL USP, with a corresponding US DMF Number 23743.
Remarkably, this DMF maintains an Active status since its submission on April 13, 2010, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 02, 2014, and payment made on October 24, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II